scispace - formally typeset
F

Farhad Islami

Researcher at American Cancer Society

Publications -  245
Citations -  74220

Farhad Islami is an academic researcher from American Cancer Society. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 70, co-authored 223 publications receiving 52150 citations. Previous affiliations of Farhad Islami include Tehran University of Medical Sciences & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Journal ArticleDOI

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Rajesh Sharma, +403 more
TL;DR: The increase in incidence rates in people younger than 50 years and the fast-rising burden in low SDI and middle SDI countries in Asia and Africa calls for colorectal cancer prevention approaches, greater awareness, and cost-effective screening and therapeutic options in these regions.
Journal ArticleDOI

Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care.

TL;DR: In this paper, the authors used complementary data sources, linked Surveillance, Epidemiology, and End Results-Medicare, and the Medical Expenditure Panel Survey to develop comprehensive estimates of patient economic burden, including out-of-pocket and patient time costs, associated with cancer care.
Journal ArticleDOI

Global and Regional Patterns of Tobacco Smoking and Tobacco Control Policies

TL;DR: country with more effective tobacco control programs have seen higher reductions in smoking prevalence and, consequently, in smoking-related mortality, and smokers should quit smoking as soon as possible.
Journal ArticleDOI

Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

Hedyeh Ebrahimi, +167 more
TL;DR: In this paper, the authors provided global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019.